版本:
中国

BRIEF-Finch Therapeutics, Takeda collaborate to develop microbiome therapeutics in inflammatory bowel disease

April 5 Takeda Pharmaceutical Co Ltd

* Finch Therapeutics and Takeda announce global collaboration to develop microbiome therapeutics in inflammatory bowel disease (ibd)

* Takeda Pharmaceutical Co Ltd says under terms of agreement, Takeda will make an upfront payment of $10 million to Finch

* Takeda Pharmaceutical Co Ltd says further details of agreement were not disclosed

* Takeda Pharmaceutical - Finch will be eligible for development, regulatory, commercial financial milestones & tiered royalties on worldwide net sales Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐